Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AbbVie (DE:4AB)
XETRA:4AB
Holding DE:4AB?
Track your performance easily
See the Price Targets and Ratings of:
4AB Analyst Ratings
Moderate Buy
11 Buy
5 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
4AB Stock 12 Month Forecast
Average Price Target
€175.16
▼(-0.77% Downside)
| Highest Price Target€194.51 | Average Price Target€175.16 | Lowest Price Target€151.68 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
Assigned
08/23/24
Morgan Stanley
Assigned
08/11/24
Evercore ISI
Reiterated
07/29/24
Wells Fargo
Assigned
07/26/24
Barclays
Reiterated
07/26/24
Truist Financial
Reiterated
07/26/24
Leerink Partners
Assigned
07/25/24
Goldman Sachs
Reiterated
07/25/24
BMO Capital
Assigned
07/25/24
J.P. Morgan
€169.53→€187.37
Buy
6.15%
Upside
Reiterated
07/25/24
Abbvie (ABBV) PT Raised to $210 at JPMorganJPMorgan analyst Chris Schott raised the price target on Abbvie (NYSE: ABBV) to $210.00 (from $190.00) while maintaining a Overweight rating.
Cantor Fitzgerald
€178.45
Buy
1.09%
Upside
Reiterated
07/25/24
Cantor Fitzgerald Sticks to Its Buy Rating for AbbVie (ABBV)
Deutsche Bank
€156.14
Hold
-11.54%
Downside
Assigned
07/17/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (NYSE: ABBV), GoodRx Holdings (NASDAQ: GDRX) and Organon (NYSE: OGN)
Bank of America Securities
€153.47
Hold
-13.06%
Downside
Reiterated
06/13/24
Hold Rating Maintained for AbbVie Amidst Revenue Erosion and Strategic Uncertainties
HSBC
€165.07
Buy
-6.49%
Downside
Upgraded
06/05/24
AbbVie upgraded to Buy from Hold at HSBCAbbVie upgraded to Buy from Hold at HSBC
Best Analysts Covering AbbVie
Which Analyst Should I Follow If I Want to Buy DE:4AB and Sell After:
1 Month
xxx
Success Rate
24/37 ratings generated profit
Average Return
+3.14%
assigned a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.86% of your transactions generating a profit, with an average return of +3.14% per trade.
3 Months
xxx
Success Rate
17/22 ratings generated profit
Average Return
+8.34%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 77.27% of your transactions generating a profit, with an average return of +8.34% per trade.
1 Year
Success Rate
14/14 ratings generated profit
Average Return
+23.37%
assigned a buy rating last month
Copying Mohit Bansal's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +23.37% per trade.
2 Years
xxx
Success Rate
23/23 ratings generated profit
Average Return
+36.16%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +36.16% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
4AB Analyst Recommendation Trends
Rating
Apr 24
May 24
Jun 24
Jul 24
Aug 24
Strong Buy
0
0
0
0
0
Buy
24
20
25
30
26
Hold
8
6
9
8
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
32
26
34
38
34
Each month's total comprises the sum of three months' worth of ratings.
4AB Financial Forecast
4AB Stock Forecast FAQ
What is DE:4AB’s average 12-month price target, according to analysts?
Based on analyst ratings, AbbVie’s 12-month average price target is €175.16.
What is DE:4AB’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:4AB, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AbbVie a Buy, Sell or Hold?
AbbVie has a consensus rating of Moderate Buy, which is based on 11 buy ratings, 5 hold ratings and 0 sell ratings.
What is AbbVie’s share price target?
The average share price target for AbbVie is €175.16. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €194.51 ,and the lowest forecast is €151.68. The average share price target represents -0.77% Decrease from the current price of €176.52.
The highest analyst share price target is €194.51 ,and the lowest forecast is €151.68. The average share price target represents -0.77% Decrease from the current price of €176.52.
What do analysts say about AbbVie?
AbbVie’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of AbbVie?
To buy shares of DE:4AB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.